Smartleaf Asset Management’s Pfizer PFE Stock Holding History

Smartleaf Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Hold	56,738	–	–	0.04%	347
2026 Q1	$1.58M	Buy	56,738 +8,445	+17%	+$225K	0.06%	298
2025 Q4	$1.21M	Buy	48,293 +15,605	+48%	+$394K	0.05%	345
2025 Q3	$780K	Buy	32,688 +13,755	+73%	+$340K	0.05%	373
2025 Q2	$458K	Sell	18,933 -9,642	-34%	-$225K	0.04%	389
2025 Q1	$720K	Buy	28,575 +5,086	+22%	+$133K	0.07%	286
2024 Q4	$621K	Sell	23,489 -952	-4%	-$25.8K	0.06%	298
2024 Q3	$711K	Buy	24,441 +12,202	+100%	+$356K	0.09%	246
2024 Q2	$340K	Sell	12,239 -285	-2%	-$7.85K	0.06%	298
2024 Q1	$348K	Buy	12,524 +5,918	+90%	+$164K	0.07%	261
2023 Q4	$186K	Buy	+6,606	New	+$200K	0.05%	325

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Smartleaf Asset Management's PFE Position: Q2 2026 in Review

Smartleaf Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 56,738 shares worth $1.38M. The position accounts for 0.04% of the portfolio, ranked #347.

Smartleaf Asset Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.58M in Q1 2026. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Smartleaf Asset Management held 56,738 shares of Pfizer worth $1.38M as of Q2 2026.
Smartleaf Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.04% of Smartleaf Asset Management's portfolio in Q2 2026, its #347 holding.
Smartleaf Asset Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's Pfizer position peaked at $1.58M in Q1 2026.
2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.